Shareholder information Share capital and security ownership Combined registers Share capital % of issued Share capital Number of ordinary Ordinary shares of 25p each 31 December 2018 holders share capital Issued ordinary shares 11,999 102,832 1.36 excluding treasury shares 2,293,770,294 2,0009,999 8,423 1.35 Treasury shares 162,645,590 10,000199,999 3,011 5.41 1 Total allotted and fully paid ordinary shares 2,456,415,884 200,000499,999 278 3.55 Aggregate nominal value m 614.1 500,000 and over 386 81.71 Note: Includes treasury shares and shares owned by employee share trusts.
Treasury shares UK 1 6.62 Total 114,931 100.00 Analyses of shareholders Ordinary Shares American Depositary Shares ADSs At 31 December 2018, there was a total of 2,456,415,884 ordinary At 31 December 2018, there was a total of 198,850,273 ADSs shares in issue held by 114,931 shareholders.
These shareholdings outstanding held by 10,225 registered holders.
The ADS register is areanalysed as follows: analysed by size of shareholding as at 31 December 2018 as follows: a by listing as at 31 December 2018: Number of % holders of total ADSs Total number % of issued Number of 11,999 9,986 1.04 Register of shares share capital holders 2,0009,999 212 0.35 UK 2,183,120,356 88.87 38,633 10,000199,999 26 0.35 South Africa 273,295,528 11.13 76,298 200,000499,999 0 0.00 Total 2,456,415,884 100.00 114,931 1 500,000 and over 1 98.26 b by size of shareholding as at 31 December 2018: Total 10,225 100.00 UK Register Note: One registered holder of ADSs represents 324,828 underlying shareholders.
% of UK Number of ordinary Security ownership of ordinary shares holders share capital As at 25 February 2019, there were 38,528 record holders of ordinary 11,999 32,563 0.65 shares listed on the LSE including Citibank as the depositary bank for 2,0009,999 4,299 0.75 the ADSs and 2,166,412,252 of such ordinary shares outstanding.
10,000199,999 1,284 2.99 As at that date, to BATs knowledge, 298 record holders, representing 200,000499,999 174 2.51 0.01% of the ordinary shares listed on the LSE, had a registered address in the United States.
As at 25 February 2019, there were 818 500,000 and over 312 85.65 record holders of ordinary shares listed on the JSE including PLC Treasury shares UK 1 7.45 Nominees Proprietary Limited as the nominee for the dematerialised Total 38,633 100.00 ordinary shares listed on the JSE and 290,004,418 of such ordinary shares outstanding.
As at such date, to BATs knowledge, no record South Africa Register holders of the ordinary shares listed on the JSE had a registered address % of SA in the United States.
As at 25 February 2019, based on information Number of ordinary received from Citibank, there were 10,150 record holders of ADSs and holders share capital 194,359,670 ADSs outstanding.
As at that date, based on information 11,999 70,269 7.02 received from Citibank, 10,069 record holders, representing 99.92% of ADSs representing ordinary shares, had a registered address in the 2,0009,999 4,124 6.10 United States.
10,000199,999 1,727 24.81 200,000499,999 104 11.77 Security ownership major shareholders 500,000 and over 74 50.30 At 31 December 2018, the following substantial interests 3% or Total 76,298 100.00 more in the Companys ordinary share capital voting securities had been notified to the Company in accordance with Section 5.1.
2 of the Disclosure Guidance and Transparency Rules DTRs.
As at 25February 2019, the Company had not received notification in accordance with the DTRs either of any change in the interests below or that any other person holds 3% or more of its ordinary shares.
Number of % of issued 1 Name ordinary shares share capital 2 The Capital Group Companies, Inc. 249,831,584 10.89 BlackRock, Inc. 132,891,526 5.79 Notes: 1.
The latest percentage of issued share capital excludes treasury shares.
Includes 21,974,376 ordinary shares represented by ADRs.
304 BAT Annual Report and Form 20-F 2018 Strategic Report Governance Financial Statements Other Information All shares held by the significant shareholders represent the Companys ordinary shares.
These significant shareholders have no special voting rights compared with other holders of the Companys ordinary shares.
Additional significant shareholding disclosure Capital Research Global Investors, a division of Capital Research and Management Company, filed with the SEC a statement on Schedule 13G under the Exchange Act on 14 February 2019 disclosing that, as of 31 December 2018, it beneficially owned 165,127,740 ordinary shares, including 20,646,872 ordinary shares represented by ADSs.
This represents approximately 7.1% of the Companys ordinary shares outstanding as of 31 December 2018.
The notifications regarding the holdings by The Capital Group Companies, Inc. listed below, indicate that Capital Research and Management Company is part of a chain of controlled undertakings with The Capital Group Companies, Inc.
In accordance with the DTRs, shareholders must notify the Company if their shareholding reaches, exceeds or falls below 3% of total voting rights and each 1% threshold thereafter.
The notifications received by the Company during the past three years to the best of the Companys knowledge are set out below.
The Capital Group Companies, Inc. notified the Company on 3 March 2016 that its interest had increased above 5% to 94,321,111 ordinary shares on 2 March 2016.
Reinet Investments S. C. A. notified the Company on 6 October 2017 that its interest had decreased below the notifiable threshold of3%to68,053,670 ordinary shares on 25 July 2017.
The Capital Group Companies, Inc. notified the Company on 15 March 2018 that its interest had increased above 10% to 229,777,471 ordinary shares on 14 March 2018.
The Capital Group Companies, Inc. notified the Company on 16 October 2018 that its interest had increased above 11% to 252,733,863 ordinary shares on 12 October 2018.
The Capital Group Companies, Inc. notified the Company on 14 January 2019 that its interest had decreased below 11% to 249,831,584 ordinary shares on 11 January 2019.
To the extent known by BAT, BAT is not directly or indirectly owned or controlled by another corporation, any foreign government or by any other natural or legal person, severally or jointly.
BAT is not aware of any arrangements, the operation of which may at a subsequent date result ina change of control of the Group.
Security ownership of the Board of Directors and the Management Board The following table presents information regarding the total amount of ordinary shares beneficially owned outright, by their family or by connected persons by each current Director of BAT, each member of the Management Board and all Directors and the Management Board as a group, as of 25 February 2019.
Unless otherwise indicated, the address for each Director and member of the Management Board listed is: c oBritish American Tobacco p. l. c. Globe House, 4 Temple Place, London, WC2R 2PG, United Kingdom.
The address for Guy Meldrum is Level30, Three Pacific Place, 1 Queens Road East, Hong Kong.
The address for Ricardo Oberlander is 401 North Main Street, Winston-Salem, NC27101, United States of America.
9 Number of Ordinary Shares Percentage of Class Directors Richard Burrows 19,000 0.0008 1,2 Nicandro Durante 380,935 0.0166 Jack Bowles 162,733 0.0071 1,2 Ben Stevens 145,524 0.0063 Sue Farr Dr Marion Helmes 4,500 0.0002 3 Luc Jobin 45,236 0.0020 3,4 Holly Keller Koeppel 8,416 0.0004 Savio Kwan 6,731 0.0003 Dimitri Panayotopoulos 3,300 0.0001 Kieran Poynter 5,000 0.0002 BAT Annual Report and Form 20-F 2018 305 Shareholder information Share capital and security ownership continued 9 Number of Ordinary Shares Percentage of Class Management Board 5,7 Jerome Abelman 58,650 0.0026 Marina Bellini 5,7 Luciano Comin 15,419 0.0007 5,7 Alan Davy 70,818 0.0031 5,7, 8 Giovanni Giordano 63,852 0.0028 5,6, 7 Hae In Kim 6,901 0.0003 5,6, 7,8 Paul Lageweg 107,385 0.0047 5,7 Tadeu Marroco 33,237 0.0014 5,7 Guy Meldrum 3,853 0.0002 5,7 David OReilly 42,079 0.0018 5,7 Ricardo Oberlander 75,243 0.0033 5,7 Naresh Sethi 69,154 0.0030 5,7 Johan Vandermeulen 36,568 0.0016 5,7 Kingsley Wheaton 29,809 0.0013 All Directors and Management Board as a group 25 persons 1,394,346 0.0608 Notes: 1.
The number of ordinary shares beneficially owned by the Executive Directors include ordinary shares awarded and required to be held for a period of at least three years in a UK-based trust under the SIP.
Ordinary shares cannot be sold or transferred out of the trust until the end of the three-year holding period.
The amounts next to the corresponding Executive Director include the following ordinary shares held in the trust under the SIP: a 2,369 ordinary shares for Mr Durante, of which 508 have been held for less than three years: b 519 ordinary shares for Mr Bowles, of which 266 have been held for less than three years: and c 693 ordinary shares for Mr Stevens, of which 306 have been held for less than three years.
In all cases, the beneficial owner of ordinary shares under the SIP may direct the trust to exercise its voting rights in accordance with his instructions.
See footnote 5 to the table below under the heading Outstanding Share-based Awards and Options-based Awards of the Board of Directors and the Management Board for additional details regarding the SIP and the ordinary shares held thereunder.
The number of ordinary shares beneficially owned by the Executive Directors include the following number of awards of restricted ordinary shares granted under the DSBS that are scheduled to vest within 60 days of 25 February 2019: a 29,690 ordinary shares for Mr Durante: b 11,473 ordinary shares for Mr Bowles: and c 19,468 ordinary shares for Mr Stevens.
Until awards of ordinary shares under the DSBS vest, they are held in trust and the recipient of such award does not have the ability to transfer, sell or direct the voting of the applicable ordinary shares.
See footnote 4 to the table below under the heading Outstanding Share-based Awards and Options-based Awards of the Board of Directors and the Management Board for additional details regarding the DSBS.
The ordinary shares beneficially owned by Mr Jobin and Ms Koeppel are represented by ADSs, each of which represents one ordinary share.
Ms Koeppel holds 21,842.98 DSUs which were granted prior to becoming a Director of BAT.
Each DSU entitles the holder to receive a cash payment upon ceasing to be a Director equal to the value of one BAT ADS.
The number of DSUs will increase on each dividend payment date by reference to the value of dividends declared on the ADSs underlying the DSUs.
The number of ordinary shares beneficially owned by the members of the Management Board include ordinary shares awarded and required to be held for a period of at least three years in a UK-based trust under the SIP.
The amounts next to the corresponding Management Board member include the following ordinary shares held in the trust under the SIP: a 489 ordinary shares for Mr Abelman, of which 268 have been held for less than three years: b 506 ordinary shares for Mr Comin, of which 270 have been held for less than three years: c 603 ordinary shares for Mr Davy, of which 290 have been held for less than three years: d 905ordinary shares for Mr Giordano, of which 322 have been held for less than three years: e 228 ordinary shares for Ms Kim, of which 228 have been held for less than three years: f 263 ordinary shares for Mr Lageweg, of which 233 have been held for less than three years: g 628 ordinary shares for Mr Marroco, of which 285 have been held for less than three years: h 225 ordinary shares for Mr Meldrum, of which 225 have been held for less than three years: i 1,757 ordinary shares for Dr OReilly, of which 439 have been held for less than three years: j 479 ordinary shares for Mr Oberlander, of which 272 have been held for less than three years: k 1,469 ordinary shares for Mr Sethi, of which 393 have been held for less than three years: l 486 ordinary shares for Mr Vandermeulen, of which 264 have been held for less than three years: and m 743 ordinary shares for Mr Wheaton, of which 309 have been held for less than three years.
The number of ordinary shares beneficially owned by the members of the Management Board include the following number of options granted under the LTIP that are scheduled to vest and may be exercised within 60 days of 25 February 2019: a 4,121 options under the LTIP for Ms Kim: and b 13,494 options under the LTIP for Mr Lageweg.
Each option is convertible into one ordinary share upon exercise.
See footnote 1 to the table below under the heading Outstanding Share-based Awards and Options-based Awards of the Board of Directors and the Management Board for additional details regarding the LTIP.
The number of ordinary shares beneficially owned by the members of the Management Board include the following number of awards of restricted ordinary shares granted under the DSBS that are scheduled to vest within 60 days of 25 February 2019: a 8,164 ordinary shares for Mr Abelman: b 3,307 ordinary shares for Mr Comin: c 8,270 ordinary shares for Mr Davy: d 10,815 ordinary shares for Mr Giordano: e 1,701 ordinary shares for Ms Kim: f 4,056 ordinary shares for Mr Lageweg: g 7,655 ordinary shares for Mr Marroco: h 3,574 ordinary shares for Mr Meldrum: i 7,655 ordinary shares for Dr OReilly: j 9,522 ordinary shares for Mr Oberlander: k 9,341 ordinary shares for Mr Sethi: l 9,013 ordinary shares for Mr Vandermeulen: and m 9,066 ordinary shares for Mr Wheaton.
The number of ordinary shares beneficially owned by the members of the Management Board include the following ADSs, each of which represents one ordinary share: a 8,000 ADSs for Mr Giordano: and b 83,416 ADSs for Mr Lageweg.
The information in this column is based on 2,293,771,080 ordinary shares outstanding excluding treasury shares as of 25 February 2019.
Any securities not outstanding subject to options, warrants, rights or conversion privileges that give the beneficial owner the right to acquire the securities within 60 days are deemed to be outstanding for the purpose of computing the percentage of outstanding securities of the class owned by such person but are not deemed to be outstanding for the purpose of computing the percentage of the class by any other person.
306 BAT Annual Report and Form 20-F 2018 Strategic Report Governance Financial Statements Other Information Outstanding Sharebased Awards and Optionsbased Awards of the Board of Directors and the Management Board The following table presents information regarding the options and the restricted share awards held by the Directors and the Management Board as of 25 February 2019.
The following Directors being the Chairman and the Non-Executive Directors have not been granted share-based Awards or Options-based Awards over ordinary shares: Mr Burrows, Ms Farr, Dr Helmes, Mr Jobin, Ms Koeppel, Mr Kwan, Mr Panayotopoulos and Mr Poynter.
LTIP: grants or awards of ordinary shares under the LTIP are for nil consideration.
The number of options shown is the maximum that may be exercised subject to the completion of the applicable performance period and conditions under the rules of the LTIP.
The number of options which may vest and become exercisable may be less than the number of ordinary shares shown in the table.
Sharesave Scheme: grants of options under the Sharesave Scheme are: a normally granted at a discount of 20% to the market price of ordinary shares at the time of invitation, as permitted by the rules of the Sharesave Scheme: and b are exercisable at the end of a three-year or five-year savings contract up to a monthly limit of 500.
Each of the LTIP and Sharesave Scheme contains provisions which permit the Board of Directors or a duly authorised committee of the Board of Directors to establish further plans for the benefit of overseas employees based on the relevant share plan but modified as necessary or desirable to take account of overseas tax, exchange control or applicable securities laws.
Any new ordinary shares issued under such plans would not count towards any applicable plan limits under the LTIP or the Sharesave Scheme.
DSBS: awards of deferred shares are made through the DSBS and comprise free ordinary shares normally held in trust for three years and no further performance conditions apply in that period.
The ordinary shares carry no rights to vote in that period.
SIP: the SIP is an all-employee plan which includes the SRS under which eligible employees receive an award of ordinary shares Free Shares in April of each year in which the plan operates in respect of performance in the previous financial year.
The Free Shares are held in a UK-based trust from the date of the award for a minimum period of three years.
During that time the SIP participant is entitled to receive dividends on those ordinary shares which are re-invested by such trust to buy further ordinary shares Dividend Shares on behalf of the SIP participant.
The Dividend Shares are also held in the trust from the date of acquisition for a minimum period of three years.
During the three-year holding periods, the SIP participant may not remove the Free Shares or the Dividend Shares from the trust, but may direct the trust to exercise its voting rights in accordance with his or her instructions.
In addition to the Free Shares and Dividend Shares, participants in the SIP are also eligible to purchase additional ordinary shares from their pre-tax salary up to an annual statutory limit Partnership Shares.
The SIP also provides that BAT has the right to offer additional ordinary shares to a participant at no cost for each Partnership Share the participant purchases, at a ratio of two such ordinary shares for each Partnership Share purchased Matching Shares.
BAT does not currently provide any Matching Shares.
BAT has established similar plans to the SIP for non-UK employees and specific plans for employees in Germany, Belgium and the Netherlands.
Each of these plans has been modified to take account of overseas tax, exchange control and applicable securities laws.
BAT Annual Report and Form 20-F 2018 315
